EE107 Ponesimod Indicated for Patients With Active Relapsing Forms of Multiple Sclerosis: A Budget Impact Analysis From the Italian National and Regional Health Care Service Perspective
Abstract
Authors
M Bellone L Pradelli M Rizzato A Franchi